Danks MK - Search Results

1

Stem and progenitor cell-mediated tumor selective gene therapy.

Aboody KS, Najbauer J, Danks MK. Aboody KS, et al. Among authors: danks mk. Gene Ther. 2008 May;15(10):739-52. doi: 10.1038/gt.2008.41. Epub 2008 Mar 27. Gene Ther. 2008. PMID: 18369324 Review.

2

Development of a tumor-selective approach to treat metastatic cancer.

Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU, Glackin CA, Potter PM, Danks MK. Aboody KS, et al. Among authors: danks mk. PLoS One. 2006 Dec 20;1(1):e23. doi: 10.1371/journal.pone.0000023. PLoS One. 2006. PMID: 17183650 Free PMC article.

3

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.

Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, Kim SU, Garcia E, Metz MZ, Najbauer J, Potter PM, Aboody KS. Danks MK, et al. Cancer Res. 2007 Jan 1;67(1):22-5. doi: 10.1158/0008-5472.CAN-06-3607. Cancer Res. 2007. PMID: 17210679

4

Neural progenitor cell-mediated delivery of interferon beta improves neuroblastoma response to cyclophosphamide.

Sims TL Jr, Hamner JB, Bush RA, Williams RF, Zhou J, Kim SU, Aboody KS, Danks MK, Davidoff AM. Sims TL Jr, et al. Among authors: danks mk. Ann Surg Oncol. 2008 Nov;15(11):3259-67. doi: 10.1245/s10434-008-0103-z. Epub 2008 Aug 23. Ann Surg Oncol. 2008. PMID: 18726131 Free PMC article.

5

Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis.

Sims TL Jr, Hamner JB, Bush RA, Fischer PE, Kim SU, Aboody KS, McCarville B, Danks MK, Davidoff AM. Sims TL Jr, et al. Among authors: danks mk. J Pediatr Surg. 2009 Jan;44(1):204-10; discussion 210-1. doi: 10.1016/j.jpedsurg.2008.10.041. J Pediatr Surg. 2009. PMID: 19159744 Free PMC article.

6

Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma.

Dickson PV, Hamner JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CY, Gray JT, Aboody KS, Danks MK, Davidoff AM. Dickson PV, et al. Among authors: danks mk. J Pediatr Surg. 2007 Jan;42(1):48-53. doi: 10.1016/j.jpedsurg.2006.09.050. J Pediatr Surg. 2007. PMID: 17208540

7

An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11.

Wierdl M, Tsurkan L, Hyatt JL, Edwards CC, Hatfield MJ, Morton CL, Houghton PJ, Danks MK, Redinbo MR, Potter PM. Wierdl M, et al. Among authors: danks mk. Cancer Gene Ther. 2008 Mar;15(3):183-92. doi: 10.1038/sj.cgt.7701112. Epub 2008 Jan 11. Cancer Gene Ther. 2008. PMID: 18188187

8

Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.

Pawlik CA, Iyengar RV, Krull EJ, Mason SE, Khanna R, Harris LC, Potter PM, Danks MK, Guichard SM. Pawlik CA, et al. Among authors: danks mk. Mol Ther. 2000 May;1(5 Pt 1):457-63. doi: 10.1006/mthe.2000.0064. Mol Ther. 2000. PMID: 10933967 Free article.

9

Cell adhesion molecules as targets for therapy of neuroblastoma.

Yoon KJ, Danks MK. Yoon KJ, et al. Among authors: danks mk. Cancer Biol Ther. 2009 Feb;8(4):306-11. doi: 10.4161/cbt.8.4.7446. Epub 2009 Feb 19. Cancer Biol Ther. 2009. PMID: 19197150 Free article. Review.

10

Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy.

Yoon KJ, Qi J, Remack JS, Virga KG, Hatfield MJ, Potter PM, Lee RE, Danks MK. Yoon KJ, et al. Among authors: danks mk. Mol Cancer Ther. 2006 Jun;5(6):1577-84. doi: 10.1158/1535-7163.MCT-06-0090. Mol Cancer Ther. 2006. PMID: 16818517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters